Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rodrigues

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
Cancers|July 25, 2019
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020Manuel Rodrigues, Leanne de Koning, Sarah E Coupland, et al.
The Oncologist|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer networkNicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, et al.
Gynecologic Oncology|November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysisCécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Bulletin Du Cancer|April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Journal of Tissue Viability|March 8, 2016
Analyses of pressure ulcer point prevalence at the first skin assessment in a Portuguese hospitalPedro Miguel Garcez Sardo, Cláudia Sofia Oliveira Simões, José Joaquim Marques Alvarelhão, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Tumori|December 7, 2024
European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary teamCristiana Sessa, Luzia Travado, Gabriele Calaminus, et al.
Gynecologic Oncology|August 8, 2025
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian DatabaseClaire Chator, Marion Chevrier, Jean-Sébastien Frenel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2023
Efficacy of chemotherapy according to <i>BRCA</i> status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapseFlora Brouillard-Saby, Caroline Saint-Martin, Isabelle Ray-Coquard, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Cancers|July 25, 2019
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020Manuel Rodrigues, Leanne de Koning, Sarah E Coupland, et al.
The Oncologist|May 11, 2025
PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer networkNicolas Rippstein, Christophe Zemmour, Manuel Rodrigues, et al.
Gynecologic Oncology|November 23, 2019
Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysisCécile Le Page, Kurosh Rahimi, Manuel Rodrigues, et al.
Bulletin Du Cancer|April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
Journal of Tissue Viability|March 8, 2016
Analyses of pressure ulcer point prevalence at the first skin assessment in a Portuguese hospitalPedro Miguel Garcez Sardo, Cláudia Sofia Oliveira Simões, José Joaquim Marques Alvarelhão, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Tumori|December 7, 2024
European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary teamCristiana Sessa, Luzia Travado, Gabriele Calaminus, et al.
Gynecologic Oncology|August 8, 2025
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian DatabaseClaire Chator, Marion Chevrier, Jean-Sébastien Frenel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2023
Efficacy of chemotherapy according to <i>BRCA</i> status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapseFlora Brouillard-Saby, Caroline Saint-Martin, Isabelle Ray-Coquard, et al.
Pageof 20